Prazosin for alcohol withdrawal symptoms in alcohol use disorder
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This study tests whether prazosin can reduce symptoms that happen when someone stops or cuts back on heavy drinking. It may help people with moderate-to-severe alcohol use disorder who also have alcohol withdrawal symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must currently have alcohol withdrawal symptoms (based on a withdrawal score or symptom check) when you start the study
- You must meet diagnostic criteria for moderate-to-severe alcohol use disorder
- You must be able to read English, answer study questionnaires, and understand consent
- You cannot have other drug use disorders (except nicotine, and sometimes limited cannabis/cocaine rules as listed) that would interfere with the study
- You must not be on certain medicines that affect the brain or blood pressure in ways that conflict with prazosin
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether combining hypnosis with aromatherapy (using calming scents) can help reduce anxiety better than standard care for people going through alcohol withdrawal. It aims to find a gentler, drug-free way to manage anxiety during detox.
This Phase 2 study tests pregnenolone to help reduce or improve alcohol use disorder symptoms. It looks for adults who drink regularly and meet diagnostic criteria for moderate to severe alcohol use disorder, while excluding people with certain other substance use, medicines, or serious mental/medical conditions.
This Phase 2 trial tests whether blocking certain body signals (alpha receptors) with a study medicine can help people with alcohol use disorder cut down or stop drinking. You may be able to join if you meet alcohol-use criteria and can safely take the study drug.
This Phase 2 study tests a brief medication approach meant to reduce “problem drinking.” It may help people cut back or stop alcohol use by adjusting brain signaling related to drinking cravings and urges.
This Phase 2 study tests whether guanfacine can reduce drinking in women and men who drink heavily and meet criteria for alcohol use disorder. It also looks at how the medicine affects drinking patterns in a controlled setting.
This study tests whether starting certain medications in the emergency room can help people with moderate to severe alcohol use disorder reduce heavy drinking and withdrawal problems after they leave the ER. It compares outcomes for participants who receive the study medications soon after an ER visit.
Hear when a new Alcohol Withdrawal trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.